| |
| |
| |
| From the laboratory to clinic: breast cancer at the turn of the century | |
| |
| |
| |
| Trends in mortality from breast cancer | |
| |
| |
| |
| |
| Changing philosophical perspectives in breast cancer | |
| |
| |
| |
| |
| Biochemical and biological markers of breast cancer progression | |
| |
| |
| |
| |
| Prognostic and predictive factors in invasice breast cancer | |
| |
| |
| |
| |
| How do anti-estrogens work? | |
| |
| |
| |
| |
| Novel chemotherapy agents for treatment of breast cancer | |
| |
| |
| |
| |
| Early detection and prevention | |
| |
| |
| |
| Identifying and counseling women at high risk of developing breast cancer | |
| |
| |
| |
| |
| Early detection and prevention: benefits, costs and limitations of screening | |
| |
| |
| |
| |
| Hazards, disadvantages and drawbacks of breast cancer screening | |
| |
| |
| |
| |
| The psychological costs of breast screening | |
| |
| |
| |
| |
| Methodological issues in the design of chemoprevention trials | |
| |
| |
| |
| |
| Chemoprevention with tamoxifen: known benefits and toxicity | |
| |
| |
| |
| |
| Could cytotoxic chemotherapy have a future in the chemoprevention of breast cancer | |
| |
| |
| |
| Current and future management | |
| |
| |
| |
| |
| To dissect or not: what is the role of auxiliary surgery in management and research? | |
| |
| |
| |
| |
| Neoadjuvant systemic primary therapy- is surgery the true adjuvant? | |
| |
| |
| |
| |
| Adjuvant radiotherapy in the management of elderly breast cancer | |
| |
| |
| |
| |
| Moving the goalposts-a review of clinical trial strategies in early breast cancer | |
| |
| |
| |
| |
| Chemotherapy for postmenopausal patients with primary breast cancer | |
| |
| |
| |
| |
| New concepts in the treatment of breast cancer using high-dose chemotherapy | |
| |
| |
| |
| |
| Adjuvant systemic chemotherapy: where do we go from here? | |
| |
| |
| |
| |
| Hormonal therapy for advanced breast cancer | |
| |
| |
| |
| |
| Improving the quality of care for breast cancer patients | |
| |
| |
| |
| Variations in practice and healthcare delivery of surgical management of breast cancer | |
| |
| |
| |
| |
| Linking research to the management of breast cancer | |
| |
| |
| |
| |
| What can patients contribute to the design of clinical trials? | |
| |
| |
| |
| |
| Variations in the management of breast cancer: Do the matter and what can be done? | |
| |
| |
| |
| |
| Measuring quality of life in patients treated for breast cancer | |
| |
| |
| |
| |
| Hormone replacement therapy and breast cancer risk | |
| |
| |
| |
| |
| Breast cancer and pregnancy | |
| |
| |
| |
| |
| An integrated policy for breast cancer management and research | |
| |